Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T22:43:48.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.
    Difference
    1%
    Check dated 2025-02-10T15:44:29.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T10:51:15.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T02:13:56.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T22:55:19.000Z thumbnail image
  9. Check
    77 days ago
    Change Detected
    Summary
    The study has transitioned to a new phase with the addition of multiple cohorts for dose expansion of Rebastinib in combination with Paclitaxel, targeting various cancers including triple-negative breast cancer and ovarian cancer, while previous entries related to completed phases and specific patient criteria have been removed.
    Difference
    98%
    Check dated 2024-12-29T13:39:54.000Z thumbnail image

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.